Pheochromocytomas and paragangliomas: assessment of malignant potential.

Pheochromocytomas and paragangliomas: assessment of malignant potential.

Show other versions (1)

Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting tumors which arise from the adrenal glands or sympathetic neuronal tissue. Malignant transformation of these tumors occurs in a significant proportion and may therefore lower overall survival rates. In patients with PPGLs...

Full description

Bibliographic Details
Main Authors:	Korevaar, T, Grossman, AB
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Pheochromocytomas and paragangliomas: assessment of malignant potential
by: Korevaar, T, et al.
Published: (2011)

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
by: Nölting, S, et al.
Published: (2012)

Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
by: Kyong Young Kim, et al.
Published: (2016-01-01)

DNA methylation analysis in malignant pheochromocytoma and paraganglioma
by: Toshihiro Oishi, et al.
Published: (2017-03-01)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
by: Anastasiya Snezhkina, et al.
Published: (2021-11-01)

Pheochromocytomas and secreting paragangliomas
by: Gimenez-Roqueplo Anne-Paule, et al.
Published: (2006-12-01)

Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience
by: Kranti Khadilkar, et al.
Published: (2016-12-01)

Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs)
by: Khatami Fatemeh, et al.
Published: (2018-01-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
by: Kaltsas, G, et al.
Published: (2003)

CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).
by: Sahdev, A, et al.
Published: (2005)

Tumour microenvironment in pheochromocytoma and paraganglioma
by: Serena Martinelli, et al.
Published: (2023-03-01)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
by: Alicja Szatko, et al.
Published: (2023-07-01)

Characteristics of pediatric pheochromocytoma/paraganglioma
by: Vijaya Sarathi
Published: (2017-01-01)

Preoperative Management of Pheochromocytoma and Paraganglioma
by: Fang Fang, et al.
Published: (2020-09-01)

Perioperative management of paragangliomas and pheochromocytomas
by: Magdalena Fermandois, et al.
Published: (2020-03-01)

Immune microenvironment of pheochromocytomas and paragangliomas
by: ZHOU Yue, TONG Anli
Published: (2024-06-01)

Pheochromocytomas and Paragangliomas Diagnosis and Treatment
by: Jorge Luis Soriano Lorenzo
Published: (2021-09-01)

The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report
by: Robin Raquel Rodriguez, et al.
Published: (2021-03-01)

External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma
by: William Breen, MD, et al.
Published: (2018-01-01)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
by: Eu Jeong Ku, et al.
Published: (2021-04-01)

Comprehensive Investigation of Angiogenesis, PASS Score and Immunohistochemical Factors in Risk Assessment of Malignancy for Paraganglioma and Pheochromocytoma
by: Marija Milinkovic, et al.
Published: (2024-04-01)

Transcriptome Analysis Reveals Significant Differences in Gene Expression of Malignant Pheochromocytoma or Paraganglioma
by: Yong Joon Suh, et al.
Published: (2019-01-01)

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
by: Camilo Jimenez
Published: (2018-05-01)

Sex differences in presentation of pheochromocytoma and paraganglioma
by: Nora Azin Ali, et al.
Published: (2025-01-01)

Hereditary and clinical insights into paraganglioma and pheochromocytoma
by: Caitlin B Mauer Hall, et al.
Published: (2024-11-01)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
by: Filippo Ceccato, et al.
Published: (2023-06-01)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
by: Laura D. Scriba, et al.
Published: (2020-02-01)

Update on Modern Management of Pheochromocytoma and Paraganglioma
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
by: Letizia Canu, et al.
Published: (2019-06-01)

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
by: Fishbein, Lauren, et al.
Published: (2018)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
by: Chrisoulidou, A, et al.
Published: (2007)

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing
by: Rute Martins, et al.
Published: (2014-01-01)

Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
by: Yuko Matsuo, et al.
Published: (2023-10-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
by: Sofia Maria Lider Burciulescu, et al.
Published: (2023-02-01)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
by: Bruna Calsina, et al.
Published: (2023-02-01)

Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
by: Marit F. van den Berg, et al.
Published: (2023-08-01)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
by: Bo Jin, et al.
Published: (2022-12-01)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
by: Christie G Turin, et al.
Published: (2023-01-01)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
by: Jiyeon Ahn, et al.
Published: (2021-06-01)

Research in Robot-assisted Surgery for Pheochromocytoma and Paraganglioma
by: OU Minjie, et al.
Published: (2024-07-01)